| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/13/2005 | WO2005002520A2 Ophthalmic compositions for treating ocular hypertension |
| 01/13/2005 | WO2005002514A2 Compounds having inhibitibe activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | WO2004050035A3 Benzimidazoles and analogs thereof as antivirals |
| 01/13/2005 | US20050010060 Novel quinones as disease therapies |
| 01/13/2005 | US20050010046 Topoisomerase poison agents |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009874 Tetrahydropyridin or piperidino heterocyclic derivatives |
| 01/13/2005 | US20050009852 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia |
| 01/13/2005 | US20050009844 Inhibitors of p38 |
| 01/13/2005 | US20050009841 N-phenylamides and ureas containing both a pyridine, pyrazine, pyrimidine, 1,2,4-triazine, imidazone or oxazine ring and a piperidine or 3,8-diazabicyclo[3.2.1]octane ring, e.g., N-(4-tert-butylphenyl)-3'-chloro-3,6-dihydro-2H-1,2'-bipyridine-4-carboxamide |
| 01/13/2005 | US20050009832 anticancer agents; antidiabetic agents; autoimmune disease; restenosis; antiarthritic agents; skin disorders; cardiovascular disorders; antiinflammatory agents |
| 01/13/2005 | US20050009831 Chemical compounds |
| 01/13/2005 | US20050009825 Cytotoxic agents |
| 01/13/2005 | US20050009824 Solubilized topoisomerase poisons |
| 01/13/2005 | US20050009823 E.g., derivatives of pyrazolo[1,5-a]pyrimidines; [1,2,3]triazolo[4,5-b]pyridines; and pyrrolo[3,2-d]pyrimidines and their use as corticotropin releasing factor antagonists |
| 01/13/2005 | US20050009822 7-(1-Acetylpentyl)-5-methyl-2-(4-methylbenzyl)imidazo[5,1-f][1,2,4]triazin-4(3H)-one; learning enhancement, concentration power, learning power, memory power; enzyme inhibitors of phosphodiesterase isoenzyme |
| 01/13/2005 | US20050009815 4-Aminoquinoline compounds |
| 01/13/2005 | US20050009813 Use of desoxypeganine for treating clinical depression |
| 01/13/2005 | US20050009802 Tertiary amino-substituted, e.g, 1(4),8(11),15(18),22(25)-tetrakis[(3-(dimethylamino)phenoxy)phthalocyaninato] zinc; and their use as photodynamic therapeutic and photodiagnostic agents. |
| 01/13/2005 | US20050008974 Writable high-capacity optical storage media containing metal complexes |
| 01/13/2005 | US20050008897 Electroluminesce; containing platinum octaethylphorphine |
| 01/13/2005 | US20050008892 Mixture of chromogens; overlapping absorption spectra; coloring high molecualr weight organic material |
| 01/13/2005 | DE10328481A1 Triazolopyrimidine Triazolopyrimidines |
| 01/13/2005 | DE10328173A1 Triazolopyrimidine Triazolopyrimidines |
| 01/13/2005 | DE10328171A1 Triazolopyrimidine Triazolopyrimidines |
| 01/13/2005 | CA2531327A1 Compounds and therapeutical use thereof |
| 01/13/2005 | CA2530886A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | CA2530081A1 Ophthalmic compositions for treating ocular hypertension |
| 01/12/2005 | EP1496059A1 Fused bicyclic pyrimidine derivatives |
| 01/12/2005 | EP1495768A1 Preventives/remedies for hotflash |
| 01/12/2005 | EP1495025A1 Cyclic compounds and the use thereof as light absorbers, light emitters, or complex ligands |
| 01/12/2005 | EP1495022A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494676A1 Fused quinoxaline derivatives as inhibitors of akt activity |
| 01/12/2005 | EP1494671A1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists |
| 01/12/2005 | EP1305314B1 Crystalline therapeutic agent |
| 01/12/2005 | EP1116722B1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES |
| 01/12/2005 | CN1564820A Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 01/12/2005 | CN1563009A Method for concurrent extracting sugarcane fat and chlorophyll from dross in sugar-refiney by using solvent |
| 01/12/2005 | CN1183989C Reaction crystallizing method for improving grain size |
| 01/11/2005 | US6841671 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 01/11/2005 | US6841567 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/11/2005 | US6841553 Contorlling fertility |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/11/2005 | CA2100924C Oxadiazine derivatives |
| 01/06/2005 | WO2005002293A2 Cox-2-targeted imaging agents |
| 01/06/2005 | WO2005000854A2 Orally bioavailable low molecular weight metalloporphyrins as antioxidants |
| 01/06/2005 | WO2005000851A1 Pyrazolopyrimidines |
| 01/06/2005 | WO2005000823A1 Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cyclene and functionalised cyclenes |
| 01/06/2005 | WO2005000821A1 Tachykinin receptor antagonists |
| 01/06/2005 | WO2005000806A2 Ligands for nicotinic acetylcholine receptors, and methods of making and using them |
| 01/06/2005 | WO2005000197A2 Selective serine/threonine kinase inhibitors |
| 01/06/2005 | WO2004096807A3 Hiv integrase inhibitors |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004159 for example, 8-(1-ethylpropyl)-3-mesityl-2,5-dimethyl-8H-pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine; having an excellent corticotrophin-releasing-factor receptor antagonistic activity |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004152 Thiazole compounds useful as inhibitors of protein kinase |
| 01/06/2005 | US20050004147 Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it |
| 01/06/2005 | US20050004144 Broad spectrum, long lasting, nontoxic synthetic immunostimulatory agents; inducing interferon production; inosine monophosphate dehydrogenase (IMPDH); cancer, autoimmune diseases |
| 01/06/2005 | US20050004143 Bi-cyclic pyrimidine inhibitors of TGFbeta |
| 01/06/2005 | US20050004131 Obesity, type II diabetes; such as 6-(4-Chlorobenzyl)-1-(2,4-dichlorobenzenesulfonyl)-8-isopropylhexahydropyrazino[1,2-a]pyrimidine-4,7-dione |
| 01/06/2005 | US20050004130 New metabotropic glutamate receptor compounds |
| 01/06/2005 | US20050004129 Pyrazole derivatives |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004118 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds |
| 01/06/2005 | US20050004117 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004108 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degenaration |
| 01/06/2005 | US20050004101 Therapy for schizophrenia, obsessive complusive disorders; antidepressants; anxiolytic agents; panic disorders; antiepileptic agents; analgesics; headaches; sleep disorders; eating disorders |
| 01/06/2005 | US20050004010 Complex with antitumor agents; therapy, diagnosis |
| 01/06/2005 | US20050002859 COX-2-targeted imaging agents |
| 01/06/2005 | CA2530408A1 Cox-2-targeted imaging agents |
| 01/06/2005 | CA2530378A1 Pyrazolopyrimidines |
| 01/06/2005 | CA2529332A1 Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cyclene and functionalised cyclenes |
| 01/06/2005 | CA2528347A1 Orally bioavailable low molecular weight metalloporphyrins as antioxidants |
| 01/05/2005 | EP1493745A1 New crystalline and amorphous form of a triazolo(4,5-D)pyrimidine compound |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1492794A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 01/05/2005 | EP1492793A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/05/2005 | EP1492792A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 01/05/2005 | EP1492790A1 Imidazo fused compounds |
| 01/05/2005 | EP1492765A2 Novel gamma secretase inhibitors |
| 01/05/2005 | EP1243333B1 High surface microporous materials which are active in oxidation reactions. tiq-6 and metiq-6 |
| 01/05/2005 | EP0912196B9 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 01/05/2005 | DE10327439A1 Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel New Imidazopyridazinon- and Imidazopyridonderivate, their preparation and their use as medicaments |
| 01/05/2005 | CN1561393A Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| 01/05/2005 | CN1183136C Indoloquinazolinones |
| 01/05/2005 | CN1183135C A novel crystalline form pyrrolo [2,3-d] pyrimidine antifolic agent and process therefor |
| 01/05/2005 | CN1183134C Tricyclic vasporessin agonists |
| 01/05/2005 | CN1183132C Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 01/05/2005 | CN1183131C Process for aqueous preparation of small size linear quinacridone |
| 01/05/2005 | CN1183129C Condensed azepines as vasporession agonists |
| 01/05/2005 | CN1183121C Method for preparing 2-(2-arylmorpholin-2-Y1) ethanol derivatives and intermediates |
| 01/05/2005 | CN1183115C 5-amino-8-methoxy quinolone carboxylic acid derivatives and its preparation |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838558 Useful in the treatment and control of solid tumors |
| 01/04/2005 | US6838477 Lactacystin analogs |